Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.4.3425322
X. Bofill, P. Cole, D. Fernández-Forner
{"title":"NME Digest - April 2022","authors":"X. Bofill, P. Cole, D. Fernández-Forner","doi":"10.1358/dof.2022.47.4.3425322","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3425322","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.7.3408811
A. Akhir, A. Dasgupta, S. Chopra
{"title":"Cefepime/enmetazobactam. Beta-Lactam/beta-lactamase inhibitor, Treatment of complicated urinary tract infection","authors":"A. Akhir, A. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.7.3408811","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3408811","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.8.3447439
M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown
{"title":"Recent Clinical Disclosures and SMR Award. Highlights from the Society for Medicines Research Conference. Virtual - December 2, 2021","authors":"M. Swarbrick, M. Hann, D.H. O'Donovan, M. Alavijeh, P. Jeffrey, K. Brown","doi":"10.1358/dof.2022.47.8.3447439","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3447439","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.9.3461263
L. Sorbera, C. Dulsat, A. Graul
{"title":"Therapeutic targets for dermatomyositis","authors":"L. Sorbera, C. Dulsat, A. Graul","doi":"10.1358/dof.2022.47.9.3461263","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3461263","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.7.3413462
Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen
{"title":"Taletrectinib adipate. Dual ROS1 and NTRK inhibitor, Treatment of non-small cell lung cancer, Treatment of solid tumors","authors":"Z. Zhang, C. Gao, X. Ma, Z. Li, C. Ashby, L. Wei, Z. Chen","doi":"10.1358/dof.2022.47.7.3413462","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3413462","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.8.3440035
P. Ghosh, V. Nehra, Z. Temesgen
{"title":"Furaprevir. HCV NS3/4A protease inhibitor, Treatment of chronic hepatitis C virus infection tract infection","authors":"P. Ghosh, V. Nehra, Z. Temesgen","doi":"10.1358/dof.2022.47.8.3440035","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3440035","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.6.3373535
A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi
{"title":"Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity","authors":"A. Sperry, J. Hardy, R. Goldfaden, A. Hurst, A. Ashchi, D. Sutton, M. Sheikh-Ali, J. Huston, R. Choksi","doi":"10.1358/dof.2022.47.6.3373535","DOIUrl":"https://doi.org/10.1358/dof.2022.47.6.3373535","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.11.3500032
A. Fernández-Llamazares, P. Cole, X. Bofill
{"title":"European Federation of Medicinal Chemistry - XXVII International Symposium on Medicinal Chemistry (EFMC-ISMC 2022). Nice - September 4-8, 2022","authors":"A. Fernández-Llamazares, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.11.3500032","DOIUrl":"https://doi.org/10.1358/dof.2022.47.11.3500032","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66441679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.2.3393240
J. Toldrà
{"title":"Society for Immunotherapy of Cancer (SITC) - 36th Annual Meeting. Virtual - November 10-14, 2021","authors":"J. Toldrà","doi":"10.1358/dof.2022.47.2.3393240","DOIUrl":"https://doi.org/10.1358/dof.2022.47.2.3393240","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66442455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.1358/dof.2022.47.8.3427161
Q. Lu, Y. Xie, Z. Zhu, G. Huang, C. Ashby, Z. Chen
{"title":"Zandelisib. Phosphatidylinositol 3-kinase delta (PI3Kdelta) inhibitor, Treatment of B-cell lymphomas","authors":"Q. Lu, Y. Xie, Z. Zhu, G. Huang, C. Ashby, Z. Chen","doi":"10.1358/dof.2022.47.8.3427161","DOIUrl":"https://doi.org/10.1358/dof.2022.47.8.3427161","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：